Role of antiplatelet agents in hematoma expansion during the acute period of intracerebral hemorrhage

Michael Moussouttas, Rishi Malhotra, Luis Fernandez, Mitchell Maltenfort, Melissa Holowecki, Jennifer Delgado, Nadine Lawson, Neeraj Badjatia

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Background: Oral anticoagulants have been associated with greater hematoma expansion in patients with intracerebral hemorrhage (ICH). The purpose of this study was to determine whether the reported use of antiplatelet agents also results in greater hematoma expansion. Methods: Retrospective review of patients with spontaneous supratentorial ICH diagnosed within 6 h of onset, who underwent follow-up head CT approximately 48 h later. Digital imaging analysis of initial and second CT scans was performed for comparison of hematoma volume changes between patients reporting and those not reporting antecedent antiplatelet use. Statistical analyses to determine predictors of ICH volume change and in-hospital mortality were also performed via multivariate regression models. Results: Of the 70 patients included, 17 were documented as taking antiplatelet agents. Groups were comparable regarding baseline demographic, clinical and laboratory characteristics, and the timing of CT scans was similar. Patients reporting antiplatelet use experienced greater absolute increase (7.7 ml vs. 5.5 ml) and proportional increase (110% vs. 21%) in ICH volume than those not reporting antiplatelet use, but these differences were not statistically significant (P = 0.94 and 0.61 respectively; Wilcoxon test). Baseline hematoma volume tended to correlate with percentage volume increase (P <0.1), whereas IVH was inversely associated with percent volume increase (P <0.05). Age (P <0.05), absolute volume increase (P <0.005), and final volume (P <0.001) were associated with in-hospital mortality, the rates of which were similar between the two study groups (18% vs. 17%). Conclusions: Patients reporting antiplatelet use experienced similar degrees of hematoma expansion compared to patients not reporting antiplatelet use.

Original languageEnglish (US)
Pages (from-to)24-29
Number of pages6
JournalNeurocritical Care
Volume12
Issue number1
DOIs
StatePublished - Feb 2010
Externally publishedYes

Fingerprint

Platelet Aggregation Inhibitors
Cerebral Hemorrhage
Hematoma
Hospital Mortality
Anticoagulants
Head
Demography
Mortality

Keywords

  • Acute
  • Antiplatelet
  • Digital image analysis
  • Enlargement
  • Expansion
  • Hematoma
  • Hemorrhage
  • Intracerebral hemorrhage
  • Volume

ASJC Scopus subject areas

  • Clinical Neurology
  • Critical Care and Intensive Care Medicine

Cite this

Moussouttas, M., Malhotra, R., Fernandez, L., Maltenfort, M., Holowecki, M., Delgado, J., ... Badjatia, N. (2010). Role of antiplatelet agents in hematoma expansion during the acute period of intracerebral hemorrhage. Neurocritical Care, 12(1), 24-29. https://doi.org/10.1007/s12028-009-9290-0

Role of antiplatelet agents in hematoma expansion during the acute period of intracerebral hemorrhage. / Moussouttas, Michael; Malhotra, Rishi; Fernandez, Luis; Maltenfort, Mitchell; Holowecki, Melissa; Delgado, Jennifer; Lawson, Nadine; Badjatia, Neeraj.

In: Neurocritical Care, Vol. 12, No. 1, 02.2010, p. 24-29.

Research output: Contribution to journalArticle

Moussouttas, M, Malhotra, R, Fernandez, L, Maltenfort, M, Holowecki, M, Delgado, J, Lawson, N & Badjatia, N 2010, 'Role of antiplatelet agents in hematoma expansion during the acute period of intracerebral hemorrhage', Neurocritical Care, vol. 12, no. 1, pp. 24-29. https://doi.org/10.1007/s12028-009-9290-0
Moussouttas, Michael ; Malhotra, Rishi ; Fernandez, Luis ; Maltenfort, Mitchell ; Holowecki, Melissa ; Delgado, Jennifer ; Lawson, Nadine ; Badjatia, Neeraj. / Role of antiplatelet agents in hematoma expansion during the acute period of intracerebral hemorrhage. In: Neurocritical Care. 2010 ; Vol. 12, No. 1. pp. 24-29.
@article{dec1f4f4eabb429bb9d0f18f43dca04f,
title = "Role of antiplatelet agents in hematoma expansion during the acute period of intracerebral hemorrhage",
abstract = "Background: Oral anticoagulants have been associated with greater hematoma expansion in patients with intracerebral hemorrhage (ICH). The purpose of this study was to determine whether the reported use of antiplatelet agents also results in greater hematoma expansion. Methods: Retrospective review of patients with spontaneous supratentorial ICH diagnosed within 6 h of onset, who underwent follow-up head CT approximately 48 h later. Digital imaging analysis of initial and second CT scans was performed for comparison of hematoma volume changes between patients reporting and those not reporting antecedent antiplatelet use. Statistical analyses to determine predictors of ICH volume change and in-hospital mortality were also performed via multivariate regression models. Results: Of the 70 patients included, 17 were documented as taking antiplatelet agents. Groups were comparable regarding baseline demographic, clinical and laboratory characteristics, and the timing of CT scans was similar. Patients reporting antiplatelet use experienced greater absolute increase (7.7 ml vs. 5.5 ml) and proportional increase (110{\%} vs. 21{\%}) in ICH volume than those not reporting antiplatelet use, but these differences were not statistically significant (P = 0.94 and 0.61 respectively; Wilcoxon test). Baseline hematoma volume tended to correlate with percentage volume increase (P <0.1), whereas IVH was inversely associated with percent volume increase (P <0.05). Age (P <0.05), absolute volume increase (P <0.005), and final volume (P <0.001) were associated with in-hospital mortality, the rates of which were similar between the two study groups (18{\%} vs. 17{\%}). Conclusions: Patients reporting antiplatelet use experienced similar degrees of hematoma expansion compared to patients not reporting antiplatelet use.",
keywords = "Acute, Antiplatelet, Digital image analysis, Enlargement, Expansion, Hematoma, Hemorrhage, Intracerebral hemorrhage, Volume",
author = "Michael Moussouttas and Rishi Malhotra and Luis Fernandez and Mitchell Maltenfort and Melissa Holowecki and Jennifer Delgado and Nadine Lawson and Neeraj Badjatia",
year = "2010",
month = "2",
doi = "10.1007/s12028-009-9290-0",
language = "English (US)",
volume = "12",
pages = "24--29",
journal = "Neurocritical Care",
issn = "1541-6933",
publisher = "Humana Press",
number = "1",

}

TY - JOUR

T1 - Role of antiplatelet agents in hematoma expansion during the acute period of intracerebral hemorrhage

AU - Moussouttas, Michael

AU - Malhotra, Rishi

AU - Fernandez, Luis

AU - Maltenfort, Mitchell

AU - Holowecki, Melissa

AU - Delgado, Jennifer

AU - Lawson, Nadine

AU - Badjatia, Neeraj

PY - 2010/2

Y1 - 2010/2

N2 - Background: Oral anticoagulants have been associated with greater hematoma expansion in patients with intracerebral hemorrhage (ICH). The purpose of this study was to determine whether the reported use of antiplatelet agents also results in greater hematoma expansion. Methods: Retrospective review of patients with spontaneous supratentorial ICH diagnosed within 6 h of onset, who underwent follow-up head CT approximately 48 h later. Digital imaging analysis of initial and second CT scans was performed for comparison of hematoma volume changes between patients reporting and those not reporting antecedent antiplatelet use. Statistical analyses to determine predictors of ICH volume change and in-hospital mortality were also performed via multivariate regression models. Results: Of the 70 patients included, 17 were documented as taking antiplatelet agents. Groups were comparable regarding baseline demographic, clinical and laboratory characteristics, and the timing of CT scans was similar. Patients reporting antiplatelet use experienced greater absolute increase (7.7 ml vs. 5.5 ml) and proportional increase (110% vs. 21%) in ICH volume than those not reporting antiplatelet use, but these differences were not statistically significant (P = 0.94 and 0.61 respectively; Wilcoxon test). Baseline hematoma volume tended to correlate with percentage volume increase (P <0.1), whereas IVH was inversely associated with percent volume increase (P <0.05). Age (P <0.05), absolute volume increase (P <0.005), and final volume (P <0.001) were associated with in-hospital mortality, the rates of which were similar between the two study groups (18% vs. 17%). Conclusions: Patients reporting antiplatelet use experienced similar degrees of hematoma expansion compared to patients not reporting antiplatelet use.

AB - Background: Oral anticoagulants have been associated with greater hematoma expansion in patients with intracerebral hemorrhage (ICH). The purpose of this study was to determine whether the reported use of antiplatelet agents also results in greater hematoma expansion. Methods: Retrospective review of patients with spontaneous supratentorial ICH diagnosed within 6 h of onset, who underwent follow-up head CT approximately 48 h later. Digital imaging analysis of initial and second CT scans was performed for comparison of hematoma volume changes between patients reporting and those not reporting antecedent antiplatelet use. Statistical analyses to determine predictors of ICH volume change and in-hospital mortality were also performed via multivariate regression models. Results: Of the 70 patients included, 17 were documented as taking antiplatelet agents. Groups were comparable regarding baseline demographic, clinical and laboratory characteristics, and the timing of CT scans was similar. Patients reporting antiplatelet use experienced greater absolute increase (7.7 ml vs. 5.5 ml) and proportional increase (110% vs. 21%) in ICH volume than those not reporting antiplatelet use, but these differences were not statistically significant (P = 0.94 and 0.61 respectively; Wilcoxon test). Baseline hematoma volume tended to correlate with percentage volume increase (P <0.1), whereas IVH was inversely associated with percent volume increase (P <0.05). Age (P <0.05), absolute volume increase (P <0.005), and final volume (P <0.001) were associated with in-hospital mortality, the rates of which were similar between the two study groups (18% vs. 17%). Conclusions: Patients reporting antiplatelet use experienced similar degrees of hematoma expansion compared to patients not reporting antiplatelet use.

KW - Acute

KW - Antiplatelet

KW - Digital image analysis

KW - Enlargement

KW - Expansion

KW - Hematoma

KW - Hemorrhage

KW - Intracerebral hemorrhage

KW - Volume

UR - http://www.scopus.com/inward/record.url?scp=76649118776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76649118776&partnerID=8YFLogxK

U2 - 10.1007/s12028-009-9290-0

DO - 10.1007/s12028-009-9290-0

M3 - Article

VL - 12

SP - 24

EP - 29

JO - Neurocritical Care

JF - Neurocritical Care

SN - 1541-6933

IS - 1

ER -